Skip to main content

Table 2 Effects of SKF96365 and La3+ alone and in combination with DHS or DMS on the muscarine-induced reductions in luminal airway area in FVB mice Effects of the Ca2+-entry inhibitors La3+ (10-6 M) and SKF 96365 (10-5 M) alone and in combination with DHS or DMS (both 10-6 M) on the muscarine induced reduction in luminal airway area (expressed in %). The number of experiments (lungs/slices), mean airway diameter in μm, and the luminal airway area determined 1 min (1) and 15 min (2) after stimulation with muscarine and 1 min (3) and 15 min (4) and after stimulation with muscarine (Mus) in combination with La3+ (Mus/La3+) or SKF96365 (Mus/SKF), or after stimulation with muscarine and La3+ or SKF96365 in combination with DHS or DMS are shown. In all experiments, the muscarine concentration was 10-6 M. Data are given as means ± S.E.M. Matched pairs (1 vs. 3; 2 vs. 4) were evaluated by Wilcoxon's rank sum test. Differences were considered as statistically significant when p < 0.05.

From: Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways

Lungs /slices

Diameter [μm]

Area [%] 1

Area [%] 2

Area [%] 3

Area [%] 4

p (1 vs. 3)

p (2 vs. 4)

4/9

212 ± 3

Mus

Mus/SKF

p < 0.05

p < 0.05

  

60 ± 7

49 ± 7

76 ± 7

86 ± 3

  

4/8

193 ± 12

Mus

Mus/SKF/DHS

p < 0.05

p < 0.05

  

51 ± 5

43 ± 6

82 ± 6

86 ± 3

  

5/6

207 ± 11

Mus

Mus/SKF/DMS

p < 0.05

p < 0.05

  

65 ± 3

53 ± 6

88 ± 2

85 ± 8

  

4/7

180 ± 8

Mus

Mus/La3+

p < 0.05

p < 0.05

  

39 ± 8

49 ± 12

65 ± 7

89 ± 2

  

4/7

211 ± 12

Mus

Mus/La3+/DHS

p < 0.05

p < 0.05

  

40 ± 4

33 ± 3

85 ± 2

89 ± 2

  

4/5

210 ± 15

Mus

Mus/La3+/DMS

p < 0.05

p < 0.05

  

45 ± 9

38 ± 9

94 ± 2

95 ± 1